Steven Sangha

Filings by Steven Sangha span 4 companies, the busiest being BetterLife Pharma Inc., Sernova Biotherapeutics Inc. and Goldhills Holding Ltd. Over a trading history stretching from 5 January 2024 to 2 October 2026, the count stands at 90 filings.

On the open market, the record shows 65 purchases worth €545k and 3 sales worth €349k. Taken together, the purchases exceed the sales by €196k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 option exercises. Since January 2026: 12 purchases and 3 sales on the market.

A typical purchase (the median) is worth €2,622. Measured against the company's value, the median purchase equals 0.023% of market capitalisation, across 3 purchases where it is known. The 56 purchases reviewed show no overlap with other insiders buying the same stock within a month.

On 6 October 2026 came the latest disclosure, a transaction in Sernova Biotherapeutics Inc. The last purchase on record was published on 1 September 2026, which is 53 days ago. Publication is fast: at least half of the trades appear on SEDI on the same day. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.